Stockholders' Equity (Details) - USD ($) |
9 Months Ended | ||||
|---|---|---|---|---|---|
May 03, 2021 |
Jun. 16, 2020 |
Sep. 30, 2021 |
Sep. 30, 2020 |
Dec. 31, 2020 |
|
| Stockholders' Equity (Details) [Line Items] | |||||
| Authorized to issue and sale of stock | 185,000,000 | ||||
| Common stock, shares authorized | 180,000,000 | ||||
| Common stock, par value (in Dollars per share) | $ 0.001 | $ 0.001 | |||
| Preferred stock, shares authorized | 5,000,000 | 5,000,000 | |||
| Preferred stock, par value (in Dollars per share) | $ 0.001 | $ 0.001 | |||
| Registration of shares, description | the Company filed a registration statement for the shares issued in its private offering (the “Private Offering”) with certain promissory note holders in December 2020. The Company converted outstanding amounts under its 8% Unsecured Promissory Notes (the “2018 Notes”) due in 2021 and 2022 in the Private Offering totaling an aggregate of $3,847,018 in principal and interest and issued 3,154,115 units at a price of $1.22 per unit. Each unit consists of one share of the Company’s common stock and one warrant to purchase 0.75 of one share of the Company’s common stock at an exercise price of $1.44 per share. Each warrant can be exercised at any time on or after June 18, 2021 and has an expiration date of June 18, 2026. Two officers of the Company participated in the Private Offering and converted an aggregate of approximately $131,000 in principal and interest into 107,000 units. | ||||
| Shares of common stock purchase | 1,300,000 | ||||
| Term, description | The stock options have terms of ten years and are subject to vesting based on continuous service of the awardee over periods ranging from three to four years. | ||||
| Cash proceeds of exercised, stock options (in Dollars) | $ 1,116,147 | $ 252,385 | |||
| Proceeds from warrant exercises (in Dollars) | $ 2,089,476 | $ 45,000 | |||
| Closing market price percentage | 85.00% | ||||
| Issued shares of under ESPP | 17,662 | ||||
| Employee compensation deferrals (in Dollars) | $ 16,814 | ||||
| Future issuance of shares under ESPP | 482,338 | ||||
| Chief Executive Officer [Member] | |||||
| Stockholders' Equity (Details) [Line Items] | |||||
| Nonqualifed stock option of purchase | 2,250,000 | ||||
| Common stock, per share (in Dollars per share) | $ 1.35 | ||||
| Based grant vest | 25.00% | ||||
| Stock option aggregate grant fair value (in Dollars) | $ 2,227,000 | ||||
| Stock Option [Member] | |||||
| Stockholders' Equity (Details) [Line Items] | |||||
| Options to purchase common stock | 783,901 | ||||
| Cash proceeds of exercised, stock options (in Dollars) | $ 1,116,147 | ||||
| Options to purchase common stock expired | 1,043,369 | ||||
| Warrants [Member] | |||||
| Stockholders' Equity (Details) [Line Items] | |||||
| Warrants to purchase of granted | 60,000 | ||||
| Exercise price (in Dollars per share) | $ 1.38 | ||||
| Vesting period, description | Fifty thousand of these warrants were valued using the Black-Scholes option pricing model and the corresponding expense will be recognized over the vesting period of one year. Ten thousand of these warrants are performance based and will be valued and expensed at the time the performance conditions are met. The warrants have terms that range from two to three years with vesting over a one-year period. | ||||
| Warrants to purchase of common stock exercised | 1,451,025 | ||||
| Proceeds from warrant exercises (in Dollars) | $ 2,089,476 | ||||
| Warrants to purchase of common stock expired | 3,181,052 | ||||
| 2011 Plan [Member] | |||||
| Stockholders' Equity (Details) [Line Items] | |||||
| Total number of shares authorized for issuance | 14,000,000 | ||||
| Remaining options to be issued | 2,900,478 | ||||
| Share-based Payment Arrangement, Option [Member] | |||||
| Stockholders' Equity (Details) [Line Items] | |||||
| Stock option aggregate grant fair value (in Dollars) | $ 5,609,846 | ||||
| Stock options granted to employees | 5,522,000 | ||||
| Share-based Payment Arrangement, Option [Member] | Minimum [Member] | |||||
| Stockholders' Equity (Details) [Line Items] | |||||
| Common stock, per share (in Dollars per share) | $ 1.1 | ||||
| Share-based Payment Arrangement, Option [Member] | Maximum [Member] | |||||
| Stockholders' Equity (Details) [Line Items] | |||||
| Common stock, per share (in Dollars per share) | $ 1.38 | ||||